Similar articles

• The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.

  Richardson DR, Ponka P. Richardson DR, et al. J Lab Clin Med. 1994 Nov;124(5):660-71. J Lab Clin Med. 1994. PMID: 7964124
• Chemical studies of pyridoxal isonicotinoyl hydrazone relevant to its clinical evaluation.

  Vitolo ML, Clare BW, Hefter GT, Webb J. Vitolo ML, et al. Birth Defects Orig Artic Ser. 1988;23(5B):71-9. Birth Defects Orig Artic Ser. 1988. PMID: 3390576 No abstract available.
• Mechanism of in vivo iron chelation by pyridoxal isonicotinoyl hydrazone and other imino derivatives of pyridoxal.

  Hershko C, Avramovici-Grisaru S, Link G, Gelfand L, Sarel S. Hershko C, et al. J Lab Clin Med. 1981 Jul;98(1):99-108. J Lab Clin Med. 1981. PMID: 7252329
• Pyridoxal isonicotinoyl hydrazone (PIH): a promising new iron chelator.

  Webb J, Vitolo ML. Webb J, et al. Birth Defects Orig Artic Ser. 1988;23(5B):63-70. Birth Defects Orig Artic Ser. 1988. PMID: 3291971 Review. No abstract available.
• Pyridoxal isonicotinoyl hydrazone and its analogues.

  Buss JL, Hermes-Lima M, Ponka P. Buss JL, et al. Adv Exp Med Biol. 2002;509:205-29. doi: 10.1007/978-1-4615-0593-8_11. Adv Exp Med Biol. 2002. PMID: 12572996 Review. No abstract available.